Wealthgarden F.S. LLC Sells 347 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Wealthgarden F.S. LLC trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 18.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,569 shares of the financial services provider’s stock after selling 347 shares during the period. Wealthgarden F.S. LLC’s holdings in iShares Biotechnology ETF were worth $207,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. BNP Paribas Financial Markets increased its holdings in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares in the last quarter. Commerce Bank increased its position in shares of iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock worth $108,234,000 after buying an additional 12,921 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its position in iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after acquiring an additional 164,000 shares during the last quarter. Main Management ETF Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 2.5% in the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after purchasing an additional 14,535 shares during the period. Finally, Aprio Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter worth approximately $18,476,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $138.91 on Friday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The firm has a fifty day simple moving average of $135.61 and a two-hundred day simple moving average of $140.77.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.